Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients
Pronounced lag in antibody production after the first dose found versus noncancer controls
WHO: Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots
Advocacy group ONE Campaign says only 1 percent of people in poor countries have received even one COVID-19 vaccine dose
Medicare Mulls Coverage for Controversial Drug for Alzheimer Disease
CMS says a final decision on coverage is not likely until next spring
Pfizer Presses U.S. Scientists, Officials on Third Booster Shot
U.S. officials say that more data are needed before regulators can determine whether booster shots are necessary
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot
Pfizer cited data from Israel showing the vaccine is declining in effectiveness as the highly contagious Delta variant circulates
ACIP: Benefits of mRNA COVID-19 Vaccines Outweigh Risks for ≥12s
After reviewing evidence, including data on risks for myocarditis, vaccination benefits outweigh risks for all populations
Omega-3 Fatty Acids Tied to Better Cardiovascular Outcomes
Cardiovascular risk reduction more prominent with EPA monotherapy versus EPA + DHA therapy
mRNA From COVID-19 Vaccines Not Detectable in Breast Milk
Authors say lactating women receiving a COVID-19 vaccine do not need to stop breastfeeding
Guidance Updated for Managing C. difficile Infection in Adults
Fidaxomicin suggested instead of vancomycin for initial Clostridioides difficile infection episode, recurrent CDI episodes
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered
